Drug-Eluting Stents for the Treatment of Intracranial Atherosclerosis.

Completed

Phase N/A Results

Summary of Purpose

To determine the feasibility and safety of using drug-eluting stents (DES) for patients with symptomatic intracranial atherosclerosis.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 June 2006.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Johnson and Johnson Corporation.

Trial Design

Prospective, clinical trial.

Contacts

Not available